Journal of Molecular Diagnostics

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Molecular Diagnostics is a journal published by Elsevier BV in United States. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,000 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1943-7811 · 1525-1578
Country
United States
Access
Not open access / not declared
Declared publication charge
3,000 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1999-01-01
Indexing
MEDLINE
APC
3,000 USD
Declared review time (DOAJ)
—
Actual review time (measured)
152 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

2786

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

132

i10-index

1610

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
76%
ORCID iDs in current deposits
74%
Deposits licence metadata at Crossref
✓
Identity & continuity4
Alternate titles
JMDAmerican journal of pathology.
Source type
journal
NLM unique ID (PubMed)
100893612
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Molecular Biology Techniques and Applications
  • Molecular Biology Techniques and Applications
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Genomics and Rare Diseases
  • Genomics and Rare Diseases
Show all subjects (50)
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Genomic variations and chromosomal abnormalities
  • Genomic variations and chromosomal abnormalities
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Big Data and Digital Economy
  • Ferroelectric and Negative Capacitance Devices
  • Big Data and Digital Economy
  • Ferroelectric and Negative Capacitance Devices
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Advanced biosensing and bioanalysis techniques
  • Advanced biosensing and bioanalysis techniques
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Prenatal Screening and Diagnostics
  • Prenatal Screening and Diagnostics
  • Gene expression and cancer classification
  • Gene expression and cancer classification
  • SARS-CoV-2 detection and testing
  • SARS-CoV-2 detection and testing
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: